Kam Shah Named to Crain’s 2022 Notable Executives of Color in Finance
Chicago, IL (July 27, 2022) – Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare industry, announced that Kam Shah was recently included as a Notable Executive of Color in Finance by Crain’s. Kam Shah, a Partner at Linden, focuses on the firm’s HCIT, diagnostics, and pharma services subsector efforts. Kam currently serves on the boards of Advarra and StatLab. Additionally, he will join the board of Aspirion upon transaction close.
Tony Davis, President and Managing Partner at Linden, said “We congratulate Kam on this tremendous recognition. Over the firm’s 18-year history, we have emphasized developing and retaining high-quality talent. Kam is a great example of a home-grown success story.” Kam first joined Linden in 2009 as an Associate and re-joined as a Vice President in 2013 after receiving his MBA from Stanford GSB. Kam was promoted to Partner in 2020. “We are proud of the team at Linden and of our retention statistics,” added Tony. Linden has not had a mid-level or senior departure from the buyout investment team since 2018.
The Linden team has grown to 52 people, including 26 investment team members. More than one-third of the Linden employees are women or people of color. Specific to the buyout team, one-third of the Investment Committee members are people of color. “At Linden, we understand the benefit of employing diverse talent,” said Katie Kornel, IR Partner and member of the firm’s D&I Committee. “We are thrilled with the progress we’ve made to attract employees from a variety of backgrounds and will remain focused on seeing a diverse slate of candidates when hiring.”
“It is a privilege to be included with this group of executives,” said Kam Shah. “I’m excited for what the future holds at Linden, as we seek to make a positive societal impact by improving the lives of our companies’ patients and customers.”
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested in over 40 healthcare companies encompassing over 200 total transactions. The firm has raised over $6 billion in limited partner commitments since inception. For more information, please visit www.lindenllc.com.
Katie Kornel for Linden Capital Partners